Damage to axons is taken as a key factor of disability in multiple sclerosi
s, but its pathogenesis is largely unknown. Axonal injury is believed to oc
cur as a consequence of demyelination and was recently shown to be a featur
e even of the early disease stages. The present study was aimed at characte
rizing the association of axonal injury and histopathological hallmarks of
multiple sclerosis such as demyelination, cellular infiltration and express
ion of inflammatory mediators. Therefore, axon reduction and signs of acute
axonal damage were quantified in early lesion development of chronic multi
ple sclerosis and correlated with demyelinating activity and inflammation.
Patients with secondary progressive multiple sclerosis revealed the most pr
onounced axonal injury, whereas primary progressive multiple sclerosis pati
ents surprisingly showed relatively little acute axonal injury. Acute axona
l damage, as defined by the accumulation of amyloid precursor protein (APP)
, was found to occur not only in active demyelinating but also in remyelina
ting and inactive demyelinated lesions with a large interindividual variabi
lity. Only few remyelinating lesions were adjacent to areas of active demye
lination, In this minority of lesions, axonal damage may have originated fr
om the neighbourhood. APP expression in damaged axons correlated with the n
umber of macrophages and CD8-positive T lymphocytes within the lesions, but
not with the expression of tumour necrosis factor-alpha (TNF-alpha) or ind
ucible nitric oxide synthase (iNOS), Axonal injury is therefore, at least i
n part, independent of demyelinating activity, and its pathogenesis may be
different from demyelination, This has major implications for therapeutic s
trategies, which aim at preventing both demyelination and axonal loss.